BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim HY, Kim N, Kang JM, Park YS, Lee DH, Kim YR, Kim JS, Jung HC, Song IS. Clinical meaning of pepsinogen test and Helicobacter pylori serology in the health check-up population in Korea: . European Journal of Gastroenterology & Hepatology 2009;21:606-12. [DOI: 10.1097/meg.0b013e3283086757] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Kim N, Jung HC. The role of serum pepsinogen in the detection of gastric cancer. Gut Liver. 2010;4:307-319. [PMID: 20981206 DOI: 10.5009/gnl.2010.4.3.307] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
2 Eybpoosh S, Talebkhan Y, Saberi S, Esmaeili M, Oghalaie A, Ebrahimzadeh F, Karimi T, Abdirad A, Nahvijou A, Mohagheghi MA, Eshagh Hosseini M, Mohammadi M. Age-Specific Gastric Cancer Risk Indicated by the Combination of Helicobacter pylori Sero-Status and Serum Pepsinogen Levels. Iran Biomed J 2015;19:133-42. [PMID: 26117138 DOI: 10.7508/ibj.2015.03.002] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
3 Hong SN, Lee SM, Kim JH, Lee TY, Kim JH, Choe WH, Lee SY, Cheon YK, Sung IK, Park HS, Shim CS. Helicobacter pylori infection increases the risk of colorectal adenomas: cross-sectional study and meta-analysis. Dig Dis Sci. 2012;57:2184-2194. [PMID: 22669208 DOI: 10.1007/s10620-012-2245-x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
4 Shan JH, Bai XJ, Han LL, Yuan Y, Sun XF. Changes with aging in gastric biomarkers levels and in biochemical factors associated with Helicobacter pylori infection in asymptomatic Chinese population. World J Gastroenterol 2017; 23(32): 5945-5953 [PMID: 28932086 DOI: 10.3748/wjg.v23.i32.5945] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
5 Kim N, Lee SW, Kim JI, Baik GH, Kim SJ, Seo GS, Oh HJ, Kim SW, Jeong H, Hong SJ. Effect of Helicobacter pylori Eradication on the Development of Reflux Esophagitis and Gastroesophageal Reflux Symptoms: A Nationwide Multi-Center Prospective Study. Gut Liver. 2011;5:437-446. [PMID: 22195241 DOI: 10.5009/gnl.2011.5.4.437] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
6 Choi YJ, Kim N, Yoon H, Shin CM, Park YS, Park JH, Nam RH, Lee DH, Jung HC. Increase in plasma acyl ghrelin levels is associated with abatement of dyspepsia following Helicobacter pylori eradication. J Gastroenterol. 2016;51:548-559. [PMID: 26412402 DOI: 10.1007/s00535-015-1124-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
7 Cao XY, Jia ZF, Jin MS, Cao DH, Kong F, Suo J, Jiang J. Serum pepsinogen II is a better diagnostic marker in gastric cancer. World J Gastroenterol 2012; 18(48): 7357-7361 [PMID: 23326145 DOI: 10.3748/wjg.v18.i48.7357] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
8 Park CH, Kim EH, Jung DH, Chung H, Park JC, Shin SK, Lee SK, Lee YC. The new modified ABCD method for gastric neoplasm screening. Gastric Cancer. 2016;19:128-135. [PMID: 25663259 DOI: 10.1007/s10120-015-0473-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
9 Hirabayashi M, Inoue M, Sawada N, Saito E, Abe SK, Hidaka A, Iwasaki M, Yamaji T, Shimazu T, Tsugane S. Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A population-based cohort study in a large Japanese population: the JPHC Study. Sci Rep. 2019;9:6099. [PMID: 30988344 DOI: 10.1038/s41598-019-42365-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
10 Di Mario F, Crafa P, Barchi A, Franzoni L, Franceschi M, Russo M, Bricca L, Brozzi L, Rodriguez Castro K, Rugge M. Pepsinogen II in gastritis and Helicobacter pylori infection. Helicobacter 2022;:e12872. [PMID: 34997989 DOI: 10.1111/hel.12872] [Reference Citation Analysis]
11 Park YH, Kim N. Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer. J Cancer Prev. 2015;20:25-40. [PMID: 25853101 DOI: 10.15430/jcp.2015.20.1.25] [Cited by in Crossref: 124] [Cited by in F6Publishing: 68] [Article Influence: 17.7] [Reference Citation Analysis]
12 Leja M, Camargo MC, Polaka I, Isajevs S, Liepniece-Karele I, Janciauskas D, Rudzite D, Kikuste I, Vanags A, Kojalo I, Folkmanis V, Kirsners A, Tolmanis I, Rabkin CS. Detection of gastric atrophy by circulating pepsinogens: A comparison of three assays. Helicobacter 2017;22. [PMID: 28557128 DOI: 10.1111/hel.12393] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
13 Lee JY, Park KS, Lee HG, Baek WK, Cho KB, Lee YJ, Lee YS, Ryu SW. Comparison of serum trefoil factor 3 with the pepsinogen test for the screening of diffuse-type gastric cancer. Clin Exp Med 2017;17:403-10. [PMID: 27154568 DOI: 10.1007/s10238-016-0426-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
14 Razuka-ebela D, Polaka I, Daugule I, Parshutin S, Santare D, Ebela I, Rudzite D, Vangravs R, Herrero R, Young Park J, Leja M. Factors Associated with False Negative Results in Serum Pepsinogen Testing for Precancerous Gastric Lesions in a European Population in the GISTAR Study. Diagnostics 2022;12:1166. [DOI: 10.3390/diagnostics12051166] [Reference Citation Analysis]
15 Zhang XM, Li JX, Zhang GY, Li XH, Gu H. The value of serum pepsinogen levels for the diagnosis of gastric diseases in Chinese Han people in midsouth China. BMC Gastroenterol. 2014;14:3. [PMID: 24383519 DOI: 10.1186/1471-230X-14-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
16 Lee HS, Jeon SW, Nomura S, Seto Y, Kwon YH, Nam SY, Ishibashi Y, Ohtsu H, Ohmoto Y, Yang HM. Screening Biomarker as an Alternative to Endoscopy for the Detection of Early Gastric Cancer: The Combination of Serum Trefoil Factor Family 3 and Pepsinogen. Gastroenterol Res Pract. 2018;2018:1024074. [PMID: 29977284 DOI: 10.1155/2018/1024074] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
17 Toyoda K, Furusyo N, Ihara T, Ikezaki H, Urita Y, Hayashi J. Serum pepsinogen and Helicobacter pylori infection--a Japanese population study. Eur J Clin Microbiol Infect Dis. 2012;31:2117-2124. [PMID: 22354521 DOI: 10.1007/s10096-011-1543-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
18 Fu S, Hu QL, Zhang L, Li ZJ. Effects of different pepsinogen cut offs in the screening of apparently healthy people. Clin Chem Lab Med 2022. [PMID: 35421289 DOI: 10.1515/cclm-2022-0080] [Reference Citation Analysis]
19 Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, Monteiro-Soares M, O'Connor A, Pereira C, Pimentel-Nunes P, Correia R, Ensari A, Dumonceau JM, Machado JC, Macedo G, Malfertheiner P, Matysiak-Budnik T, Megraud F, Miki K, O'Morain C, Peek RM, Ponchon T, Ristimaki A, Rembacken B, Carneiro F, Kuipers EJ; European Society of Gastrointestinal Endoscopy., European Helicobacter Study Group., European Society of Pathology., Sociedade Portuguesa de Endoscopia Digestiva. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012;44:74-94. [PMID: 22198778 DOI: 10.1055/s-0031-1291491] [Cited by in Crossref: 389] [Cited by in F6Publishing: 344] [Article Influence: 35.4] [Reference Citation Analysis]